<SEC-DOCUMENT>0001193125-22-171605.txt : 20220610
<SEC-HEADER>0001193125-22-171605.hdr.sgml : 20220610
<ACCEPTANCE-DATETIME>20220610100632
ACCESSION NUMBER:		0001193125-22-171605
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20220606
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220610
DATE AS OF CHANGE:		20220610

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GOODYEAR TIRE & RUBBER CO /OH/
		CENTRAL INDEX KEY:			0000042582
		STANDARD INDUSTRIAL CLASSIFICATION:	TIRES AND INNER TUBES [3011]
		IRS NUMBER:				340253240
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01927
		FILM NUMBER:		221007876

	BUSINESS ADDRESS:	
		STREET 1:		1144 E MARKET ST
		CITY:			AKRON
		STATE:			OH
		ZIP:			44316
		BUSINESS PHONE:		2167962121

	MAIL ADDRESS:	
		STREET 1:		1144 E MARKET ST
		CITY:			AKRON
		STATE:			OH
		ZIP:			44316
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d373071d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gt="http://corporate.goodyear.com/20220606" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2022-06-06_to_2022-06-06">GOODYEAR TIRE &amp; RUBBER CO /OH/</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-06-06_to_2022-06-06">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-06-06_to_2022-06-06">0000042582</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="gt-20220606.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-06-06_to_2022-06-06"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000042582</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-06-06</xbrli:startDate> <xbrli:endDate>2022-06-06</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-06-06_to_2022-06-06">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of Earliest Event Reported):&#160;&#160;<span style="font-family:Times New Roman; font-size:1pt;color:#ffffff">(</span><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-06-06_to_2022-06-06" format="ixt:datemonthdayyearen">June 6, 2022</ix:nonNumeric><span style="font-family:Times New Roman; font-size:1pt;color:#ffffff">)</span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:1pt; font-family:Times New Roman;text-align:center"><span style="color:#ffffff"><span style="font-weight:bold">Month 1, 2022 </span></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">THE GOODYEAR TIRE &amp; RUBBER COMPANY</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-06-06_to_2022-06-06" format="ixt-sec:stateprovnameen">Ohio</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-06-06_to_2022-06-06">1-1927</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-06-06_to_2022-06-06">34-0253240</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-06-06_to_2022-06-06">200 Innovation Way</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-06-06_to_2022-06-06">Akron</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-06-06_to_2022-06-06" format="ixt-sec:stateprovnameen">Ohio</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-06-06_to_2022-06-06">44316-0001</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-06-06_to_2022-06-06">(330)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-06-06_to_2022-06-06">796-2121</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Former name or former address, if changed since last report</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-06-06_to_2022-06-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-06-06_to_2022-06-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-06-06_to_2022-06-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-06-06_to_2022-06-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-06-06_to_2022-06-06">Common Stock, Without Par Value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-06-06_to_2022-06-06">GT</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-06-06_to_2022-06-06" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-06-06_to_2022-06-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;6, 2022, the Compensation Committee of the Board of Directors of The Goodyear Tire&#160;&amp; Rubber Company approved forms of grant agreements under the 2022 Performance Plan for <span style="white-space:nowrap">non-qualified</span> stock options, <span style="white-space:nowrap">non-qualified</span> stock options with tandem stock appreciation rights, performance shares, cash-based performance units and restricted stock units. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:94%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d373071dex101.htm">Form of <span style="white-space:nowrap">Non-Qualified</span> Stock Option Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d373071dex102.htm">Form of <span style="white-space:nowrap">Non-Qualified</span> Stock Option with tandem Stock Appreciation Right Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d373071dex103.htm">Form of Performance Share Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d373071dex104.htm">Form of Performance Share Continuous Vesting Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d373071dex105.htm">Form of Executive Performance Unit Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.6</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d373071dex106.htm">Form of Executive Performance Unit Continuous Vesting Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.7</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d373071dex107.htm">Form of Restricted Stock Unit Annual Cliff Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.8</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d373071dex108.htm">Form of Restricted Stock Unit Annual Ratable Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.9</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d373071dex109.htm">Form of Restricted Stock Unit Continuous Vesting Grant Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: June 10, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">THE GOODYEAR TIRE&#160;&amp; RUBBER COMPANY</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel T. Young</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Daniel T. Young</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d373071dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.1 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option Grant Agreement </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. These <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options for the number of shares of Common Stock indicated on the grant summary page (the <FONT
STYLE="white-space:nowrap">&#147;Non-Qualified</FONT> Stock Options&#148;) are granted to you under and are governed by the terms and conditions of the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective
April&nbsp;11, 2022 (as amended from time to time, the &#147;Plan&#148;), and this Grant Agreement. As your stock options are conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and
conditions of the Plan and this Grant Agreement. You also agree that you have read and understand the Plan and this Grant Agreement. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. You may exercise the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options granted pursuant to this Grant Agreement through (1)&nbsp;a cash
payment in the amount of the full option exercise price of the shares being purchased (including a simultaneous exercise and sale of the shares of Common Stock thereby acquired and use of the proceeds from such sale to pay the exercise price, to the
extent permitted by law) (a &#147;cash exercise&#148;), (2) a payment in full shares of Common Stock having a Fair Market Value on the date of exercise equal to the full option exercise price of the shares of Common Stock being purchased (a
&#147;share swap exercise&#148;), or (3)&nbsp;a combination of the cash exercise and share swap exercise methods. Any exercise of these <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options shall be by written notice stating the number
of shares of Common Stock to be purchased and the exercise method, accompanied with the payment, and proper proof of ownership if the share swap exercise method is used. You shall be required to meet the tax withholding obligations arising from any
exercise of <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. As further consideration for the
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options granted to you hereunder, you must remain in the continuous employ of the Company or one or more of its Subsidiaries from the Date of Grant to the date or dates the <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options become exercisable as set forth on the grant summary page of this Grant Agreement before you will be entitled to exercise the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock
Options granted. The <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options you have been granted shall not in any event be exercisable after your termination of employment except as provided in paragraph 4 below for
&#147;Retirement&#148; (defined as termination of employment at any age after 30 or more years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries), death, &#147;Disability&#148; (defined as
termination of employment while receiving benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries), or termination of your employment by
the Company and its Subsidiaries other than for Cause (as defined below). Notwithstanding the foregoing, in the event of a Change in Control while this grant is outstanding, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options
shall be subject to the applicable provisions of Section&nbsp;14 of the Plan. For the avoidance of doubt, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options you have been granted shall not be exercisable after termination of
employment as a result of your voluntary resignation (other than your Retirement), except as otherwise may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. Except as otherwise may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control, the
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options terminate automatically and shall not be exercisable by you from and after the date on which you cease to be an employee of the Company or one of its Subsidiaries for any reason
other than your death, Retirement, Disability, or termination of your employment by the Company and its Subsidiaries other than for Cause. In the event of your death, Retirement or Disability while an employee of the Company or one of its
Subsidiaries (and having been an employee continuously since the Date of Grant) on any date which is more than six (6)&nbsp;months after the Date of Grant of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options specified on the
grant summary page of this Grant Agreement, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options shall become immediately exercisable and, except as provided below in the event of your death while an employee, shall be exercisable
by you for the lesser of (a)&nbsp;the remainder of the term of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option grant or (b)&nbsp;five years. In the event of your death while an employee, the
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option Grant Agreement </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options may be exercised for the lesser of (x)&nbsp;the remainder of the term of the <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option grant or (y)&nbsp;three years after your date of death by the person or persons to whom your rights in the options passed by your will or according to the laws of descent and distribution.
In the event of termination of your employment by the Company and its Subsidiaries other than for death, Disability or Cause, any vested <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options shall remain exercisable by you for 90 days
following the date of termination of your employment. For purposes of this Grant Agreement, &#147;Cause&#148; means (i)&nbsp;the continued failure by you to substantially perform your duties with the Company or its affiliates (other than any such
failure resulting from your incapacity due to physical or mental illness), (ii) your engaging in conduct which is demonstrably injurious to the Company or its affiliates, monetarily or otherwise, (iii)&nbsp;your committing any felony or any crime
involving fraud, breach of trust or misappropriation, or (iv)&nbsp;any breach or violation of any agreement relating to your employment with the Company or its affiliates where the Committee, in its sole but reasonable discretion, determines that
such breach or violation materially and adversely affects the Company or any affiliate. Nothing contained herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to terminate your employment at any time, with or
without Cause. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options shall not in any event be exercisable after the expiration of
ten years from the Date of Grant specified on the grant summary page of this Grant Agreement and, to the extent not exercised, shall automatically terminate at the end of such <FONT STYLE="white-space:nowrap">ten-year</FONT> period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. Certificates, or other evidence of beneficial ownership, for the shares of Common Stock purchased will be deliverable to you or your agent, duly accredited
to the satisfaction of the Company, at the principal office of the Company in Akron, Ohio, or at such other place acceptable to the Company as may be designated by you. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. In the event your employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether voluntarily or involuntarily) and within
18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if not received) to forfeit, to the Company
the economic value of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options granted hereunder which you have realized or obtained by your exercise at any time on or after the date which is six months prior to the date of
termination of your employment with the Company. Additionally, all <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options granted to you hereunder which you have not exercised shall be automatically cancelled upon commencement of your
competitive engagement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Each <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option granted is not transferable by you otherwise than by
will or the laws of descent and distribution, and is exercisable during your lifetime only by you. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. All rights conferred upon you under the provisions
of this Grant Agreement are personal and, except under the provisions of paragraph 8 of this Grant Agreement, no assignee, transferee or other successor in interest shall acquire any rights or interests whatsoever under this Grant Agreement, which
is made exclusively for the benefit of you and the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. Any notice to you under this Grant Agreement shall be sufficient if in writing and if
delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the Executive Compensation Department of
the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company may, by written notice, change the
address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option Grant Agreement </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. Each <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option may be exercised only at the times and to the extent, and is subject to all of the
terms and conditions, set forth in this Grant Agreement, and in the Plan, including any rule or regulation adopted by the Committee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. In order to
administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to the information provided in this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as
home and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the
Company to process any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to
transferees that shall include the Company and other persons who are designated by the Company to administer the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. By accepting this Grant
Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to
receiving the Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are
familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms and subject to the conditions set forth herein and in the Plan. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d373071dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.2 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option with tandem Stock Appreciation Right Grant Agreement </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. These <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options for the number of shares of Common Stock indicated on the grant summary page (the <FONT
STYLE="white-space:nowrap">&#147;Non-Qualified</FONT> Stock Options&#148;) and the Stock Appreciation Rights granted in tandem with the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options (the &#147;SARs&#148;) are granted to you
under and are governed by the terms and conditions of the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time, the &#147;Plan&#148;), and this Grant Agreement. As
your stock options are conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement, including a recognition of the Company&#146;s right to specify
whether or not you may exercise either the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options or the SARs at the time you notify the Company of your intent to exercise. In the event that you are, or become subject to taxation under
the laws of the United States of America at any time prior to the expiration date, the grant hereunder shall be deemed to be a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option and not a SAR for so long as you remain subject to such
tax laws. You also agree that you have read and understand the Plan and this Grant Agreement. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. If the Company approves the exercise of a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option, you may exercise the <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options granted pursuant to this Grant Agreement through (1)&nbsp;a cash payment in the amount of the full option exercise price of the shares being purchased (including a simultaneous exercise
and sale of the shares of Common Stock thereby acquired and use of the proceeds from such sale to pay the exercise price, to the extent permitted by law) (a &#147;cash exercise&#148;), (2)&nbsp;a payment in full shares of Common Stock having a Fair
Market Value on the date of exercise equal to the full option exercise price of the shares of Common Stock being purchased (a &#147;share swap exercise&#148;), or (3)&nbsp;a combination of the cash exercise and share swap exercise methods. Any
exercise of these <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options shall be by written notice stating the number of shares of Common Stock to be purchased and the exercise method, accompanied with the payment, and proper proof of
ownership if the share swap exercise method is used. You shall be required to meet the tax withholding obligations arising from any exercise of <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. If the Company approves the exercise of the SARs, written notice must be given to the Company stating the number of shares of Common Stock in respect of
which the SARs are being exercised. In due course, you will receive payment in cash in an amount equal to the excess, if any, of the Fair Market Value of one share of Common Stock on the date of exercise of the SARs over the Option Exercise Price
per Share specified in respect of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options multiplied by the number of shares of Common Stock in respect of which the SARs shall have been exercised. Such payment shall be subject to
reduction for withholding taxes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. As further consideration for the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs granted
to you hereunder, you must remain in the continuous employ of the Company or one or more of its Subsidiaries from the Date of Grant to the date or dates the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs become
exercisable as set forth on the grant summary page of this Grant Agreement before you will be entitled to exercise the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs granted. The
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs you have been granted shall not in any event be exercisable after your termination of employment except as provided in paragraph 5 below for &#147;Retirement&#148; (defined
as termination of employment at any age after 30 or more years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries), death, &#147;Disability&#148; (defined as termination of employment while
receiving benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries), or termination of your employment by the Company and its
Subsidiaries other than for Cause (as defined below). Notwithstanding the foregoing, in the event of a Change in Control while this grant is outstanding, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs shall be
subject to the applicable provisions of Section&nbsp;14 of the Plan. For the avoidance of doubt, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs you have been granted shall not be exercisable after termination of
employment as a result of your voluntary resignation (other than your Retirement), except as otherwise may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option with tandem Stock Appreciation Right
Grant Agreement </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. Except as otherwise may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control, the <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs terminate automatically and shall not be exercisable by you from and after the date on which you cease to be an employee of the Company or one of its Subsidiaries for any reason
other than your death, Retirement, Disability, or termination of your employment by the Company and its Subsidiaries other than for Cause. In the event of your death, Retirement or Disability while an employee of the Company or one of its
Subsidiaries (and having been an employee continuously since the Date of Grant) on any date which is more than six (6)&nbsp;months after the Date of Grant specified on the grant summary page of this Grant Agreement, the <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs shall become immediately exercisable and, except as provided below in the event of your death while an employee, shall be exercisable by you for the lesser of (a)&nbsp;the
remainder of the term of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option/SAR grant or (b)&nbsp;five years. In the event of your death while an employee, the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options
and SARs may be exercised for the lesser of (x)&nbsp;the remainder of the term of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option/SAR grant or (y)&nbsp;three years after your date of death by the person or persons to whom your
rights in the options passed by your will or according to the laws of descent and distribution. In the event of termination of your employment by the Company and its Subsidiaries other than for death, Disability or Cause, any vested <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs shall remain exercisable by you for 90 days following the date of termination of your employment. For purposes of this Grant Agreement, &#147;Cause&#148; means (i)&nbsp;the
continued failure by you to substantially perform your duties with the Company or its affiliates (other than any such failure resulting from your incapacity due to physical or mental illness), (ii)&nbsp;your engaging in conduct which is demonstrably
injurious to the Company or its affiliates, monetarily or otherwise, (iii)&nbsp;your committing any felony or any crime involving fraud, breach of trust or misappropriation, or (iv)&nbsp;any breach or violation of any agreement relating to your
employment with the Company or its affiliates where the Committee, in its sole but reasonable discretion, determines that such breach or violation materially and adversely affects the Company or any affiliate. Nothing contained herein shall restrict
the right of the Company or any of its Subsidiaries or affiliates to terminate your employment at any time, with or without Cause. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. The <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options and SARs shall not in any event be exercisable after the expiration of ten years from the Date of Grant specified on the grant summary page of this Grant Agreement and, to the extent not
exercised, shall automatically terminate at the end of such <FONT STYLE="white-space:nowrap">ten-year</FONT> period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. Certificates, or other evidence of
beneficial ownership, for the shares of Common Stock purchased pursuant to <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options will be deliverable to you or your agent, duly accredited to the satisfaction of the Company, at the
principal office of the Company in Akron, Ohio, or at such other place acceptable to the Company as may be designated by you. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. In the event your
employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether voluntarily or involuntarily) and within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in
competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if not received) to forfeit, to the Company the economic value of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options or SARs
which you have realized or obtained by your exercise of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options or SARs granted hereunder at any time on or after the date which is six months prior to the date of termination of your
employment with the Company. Additionally, all <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options or SARs granted to you hereunder which you have not exercised shall be automatically cancelled upon commencement of your competitive
engagement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. Each <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option and SAR granted are not transferable by you otherwise than by will
or the laws of descent and distribution, and are exercisable during your lifetime only by you. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option with tandem Stock Appreciation Right
Grant Agreement </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. All rights conferred upon you under the provisions of this Grant Agreement are personal and, except under the provisions of paragraph
9 of this Grant Agreement, no assignee, transferee or other successor in interest shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. Any notice to you under this Grant Agreement shall be sufficient if in writing and if delivered to you or mailed to you at the address on record in the
Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed
to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company may, by written notice, change the address. This Grant Agreement shall be construed and shall take
effect in accordance with the laws of the State of Ohio. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. Each <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option and/or SAR may be
exercised only at the times and to the extent, and is subject to all of the terms and conditions, set forth in this Grant Agreement, and in the Plan, including any rule or regulation adopted by the Committee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. Your purchase of shares of Common Stock pursuant to the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options shall automatically reduce by a
like number the shares of Common Stock subject to the SARs and, conversely, your exercise of any SARs shall automatically reduce by a like number the shares of Common Stock available for purchase by you under the
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14. In agreeing to accept this grant, you clearly acknowledge that The Goodyear
Tire&nbsp;&amp; Rubber Company assumes no responsibility for any regulatory or tax consequences that arise from either the grant or exercise of the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options or the SARs, whether under U.S.
or foreign law, rules, regulations or treaties. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15. Prior to the exercise of a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option or SAR,
written notice must be given to the Company of your intent to exercise. The Company will then advise you whether or not you may exercise a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option or SAR and upon receiving such advice you
may then exercise the <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option or the SAR. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16. In order to administer the Plan, the Company may
process personal data about you. Such data includes, but is not limited to the information provided in this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and
other contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such
personal data. You also give explicit consent to the Company to transfer any such personal data outside the country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include
the Company and other persons who are designated by the Company to administer the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">17. By accepting this Grant Agreement, you acknowledge that a copy
of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information
electronically, or, in the alternative, agree to contact the Executive Compensation Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions
of the Prospectus Information and hereby accept this Grant Agreement on the terms and subject to the conditions set forth herein and in the Plan. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>d373071dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.3 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance Share Annual Grant Agreement </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. This Performance
Share Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time, the &#147;Plan&#148;),
and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree that you have read and
understand the provisions of the Plan, this Grant Agreement and Annex A: 20__ &#150; 20__ LTI Targets and Ranges, referred to as &#147;Annex A&#148;. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other successor in
interest shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. Except as otherwise provided in this Section&nbsp;3 or as may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control, the
number of Units earned will be determined and contingent upon the extent to which Performance Goals are achieved during a Performance Period, as described in Annex A and as determined by the Committee. As further consideration for the Units granted
to you hereunder, except as otherwise provided in this Section&nbsp;3, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until <B>December</B><B></B><B>&nbsp;31, 20__</B> (the &#147;Vesting Date&#148;). In
the event of your death, &#147;Retirement&#148; (defined as termination of employment at any age after 30 or more years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries) or
&#147;Disability&#148; (defined as termination of employment while receiving benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries) on
any date which is more than six (6)&nbsp;months after the Date of Grant and prior to completion of a Performance Period, you will receive a prorated number of Units. Any such proration will be based on the date of your termination of employment with
the Company and actual achievement of the Performance Goals as determined by the Committee following the end of the Performance Period. In the event of your death, Retirement or Disability on or prior to the Vesting Date but after completion of a
Performance Period, you will receive the number of Units earned as determined by the Committee following the end of the Performance Period, which will be payable as provided in Section&nbsp;5. Nothing contained herein shall restrict the right of the
Company or any of its Subsidiaries or affiliates to terminate your employment at any time, with or without cause. Further, notwithstanding Section&nbsp;14(a)(2) of the Plan, in the event that you incur a Severance before or during a Performance
Period, the Units with respect to any such Performance Period shall be deemed to have been fully earned at the target amount of the award opportunity, and in the event that you incur a Severance on or prior to the Vesting Date but after completion
of a Performance Period, the Units with respect to any such completed Performance Period shall be deemed to have been fully earned in the amount determined by the Committee following the end of the Performance Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. In the event your employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether voluntarily or involuntarily) and
within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if not received) to forfeit, to the
Company the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of termination of your employment with the Company. Additionally, all Units granted
to you hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance Share Annual Grant Agreement </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The Company will pay to you 100% of the total number of whole Units earned in shares of Common Stock (with each Unit being equivalent to one share of Common
Stock), less such withholding and payroll taxes as the Company shall determine to be necessary or appropriate. Any payment pursuant to Section&nbsp;5 of this Grant Agreement shall be made (i)&nbsp;after the Vesting Date but in no event later than
<B>March</B><B></B><B>&nbsp;15, 20__;</B> or (ii)&nbsp;in the event of your earlier Severance, within 30 days after your Severance. The number of Units earned will always be rounded down to the nearest whole number, and the Company will not be
obligated to issue any fractional shares of Common Stock (or pay any cash in lieu thereof) pursuant to this Grant Agreement. Further, no Dividend Equivalents will be paid or provided pursuant to this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. You will be required to satisfy all Federal, state and local tax and payroll withholding obligations, and any other withholding obligations, arising in
respect of any distribution of, or right to receive any distribution of, shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. Any notice to you under this Grant Agreement shall be
sufficient if in writing and if delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the
Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company
may, by written notice, change the address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. The obligations of the Company under this Grant Agreement will be merely that of an unfunded and unsecured promise of the Company to deliver shares of
Common Stock in the future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the requirements of Section&nbsp;409A of the Code.
This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Units shall not be
deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from the requirements of Section&nbsp;409A of the
Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this Grant
Agreement to the contrary, if you are a &#147;specified employee,&#148; within the meaning of Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the specified
employee effective date, on the date you incur a separation from service, then to the extent required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of
compensation&#148; within the meaning of Section&nbsp;409A of the Code, that are provided as a result of a separation from service and that would otherwise be paid during the first six months following such separation from service shall be
accumulated through and paid on the first business day that is more than six months following your separation from service (or, if you die during such <FONT STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance Share Annual Grant Agreement </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. In order to administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to the information provided in
this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to
facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the
country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. By accepting this Grant Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy
Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation
Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms
and subject to the conditions set forth herein and in the Plan. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>d373071dex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.4 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance Share Continuous Vesting Grant Agreement </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. This
Performance Share Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time, the
&#147;Plan&#148;), and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree that you
have read and understand the provisions of the Plan, this Grant Agreement and Annex A: 20__ &#150; 20__ LTI Targets and Ranges, referred to as &#147;Annex A&#148;. Capitalized terms used but not defined in this Grant Agreement have the meanings set
forth in the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other
successor in interest shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. Except as otherwise provided in this Section&nbsp;3 or as may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control, the
number of Units earned will be determined and contingent upon the extent to which Performance Goals are achieved during a Performance Period, as described in Annex A and as determined by the Committee. As further consideration for the Units granted
to you hereunder, except as otherwise provided in this Section&nbsp;3, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until <B>December</B><B></B><B>&nbsp;31, 20__</B> (the &#147;Vesting Date&#148;). In
the event of your death, &#147;Retirement&#148; (defined as termination of employment at any age after 30 or more years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries) or
&#147;Disability&#148; (defined as termination of employment while receiving benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries) on
any date which is more than six (6)&nbsp;months after the Date of Grant and prior to completion of a Performance Period, you will receive a prorated number of Units; provided, however, that if you remain in the continuous employ of the Company or
one or more of its Subsidiaries until at least <B>December</B><B></B><B>&nbsp;31, 20__</B>, the Units granted to you hereunder will be deemed to be fully vested and you will receive the number of Units actually earned as determined by the Committee
following the end of the Performance Period, which will be payable as provided in Section&nbsp;5. Any such proration will be based on the date of your termination of employment with the Company and actual achievement of the Performance Goals as
determined by the Committee following the end of the Performance Period. In the event of your death, Retirement or Disability on or prior to the Vesting Date but after completion of a Performance Period, you will receive the number of Units earned
as determined by the Committee following the end of the Performance Period, which will be payable as provided in Section&nbsp;5. Nothing contained herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to terminate
your employment at any time, with or without cause. Further, notwithstanding Section&nbsp;14(a)(2) of the Plan, in the event that you incur a Severance before or during a Performance Period, the Units with respect to any such Performance Period
shall be deemed to have been fully earned at the target amount of the award opportunity, and in the event that you incur a Severance on or prior to the Vesting Date but after completion of a Performance Period, the Units with respect to any such
completed Performance Period shall be deemed to have been fully earned in the amount determined by the Committee following the end of the Performance Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. In the event your employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether voluntarily or involuntarily) and within
18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if not received) to forfeit, to the Company
the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of termination of your employment with the Company.
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Performance Share Continuous Vesting Grant Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, all Units granted to you
hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The Company will pay to you 100% of
the total number of whole Units earned in shares of Common Stock (with each Unit being equivalent to one share of Common Stock), less such withholding and payroll taxes as the Company shall determine to be necessary or appropriate. Any payment
pursuant to Section&nbsp;5 of this Grant Agreement shall be made (i)&nbsp;after the Vesting Date but in no event later than <B>March</B><B></B><B>&nbsp;15, 20__</B>; or (ii)&nbsp;in the event of your earlier Severance, within 30 days after your
Severance. The number of Units earned will always be rounded down to the nearest whole number, and the Company will not be obligated to issue any fractional shares of Common Stock (or pay any cash in lieu thereof) pursuant to this Grant Agreement.
Further, no Dividend Equivalents will be paid or provided pursuant to this Grant Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. You will be required to satisfy all Federal, state and
local tax and payroll withholding obligations, and any other withholding obligations, arising in respect of any distribution of, or right to receive any distribution of, shares of Common Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. Any notice to you under this Grant Agreement shall be sufficient if in writing and if delivered to you or mailed to you at the address on record in the
Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed
to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company may, by written notice, change the address. This Grant Agreement shall be construed and shall take
effect in accordance with the laws of the State of Ohio. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. The obligations of the Company under this Grant Agreement will be merely that of an unfunded
and unsecured promise of the Company to deliver shares of Common Stock in the future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations
of the Company under this Grant Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the
requirements of Section&nbsp;409A of the Code. This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without
limiting the foregoing, the Units shall not be deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from
the requirements of Section&nbsp;409A of the Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this Grant Agreement to the contrary, if you are a &#147;specified employee,&#148; within the meaning of
Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the specified employee effective date, on the date you incur a separation from service, then to the extent
required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of compensation&#148; within the meaning of Section&nbsp;409A of the Code, that are provided as a result of a
separation from service and that would otherwise be paid during the first six months following such separation from service shall be accumulated through and paid on the first business day that is more than six months following your separation from
service (or, if you die during such <FONT STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Performance Share Continuous Vesting Grant Agreement </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. In order to administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to the information provided in
this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to
facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the
country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. By accepting this Grant Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy
Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation
Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms
and subject to the conditions set forth herein and in the Plan. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>d373071dex105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.5 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Performance Unit Grant Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. This Executive
Performance Unit Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time, the
&#147;Plan&#148;), and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree that you
have read and understand the provisions of the Plan, this Grant Agreement and Annex A: 20_ &#150; 20_ LTI Targets and Ranges, referred to as &#147;Annex A&#148;. Capitalized terms used but not defined in this Grant Agreement have the meanings set
forth in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other
successor in interest shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. Except as otherwise provided in Section&nbsp;4 or as may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control, the
number of Units earned (the &#147;Performance Award&#148;) will be determined and contingent upon the extent to which Performance Goals are achieved during a Performance Period, as described in Annex A and as determined by the Committee, and will be
paid as provided in Section&nbsp;7 of this Grant Agreement. All Performance Awards will be paid in cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. As further consideration for the Units
granted to you hereunder, except as otherwise provided in this Section&nbsp;4, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until <B>December</B><B></B><B>&nbsp;31, 20__</B> (the &#147;Vesting
Date&#148;). In the event of your death, &#147;Retirement&#148; (defined as termination of employment at any age after 30 or more years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries) or
&#147;Disability&#148; (defined as termination of employment while receiving benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries) on
any date which is more than six (6)&nbsp;months after the Date of Grant and prior to completion of a Performance Period, you will receive a prorated number of Units. Any such proration will be based on the date of your termination of employment with
the Company and actual achievement of the Performance Goals as determined by the Committee following the end of the Performance Period. In the event of your death, Retirement or Disability on or prior to the Vesting Date but after completion of a
Performance Period, you will receive the number of Units earned as determined by the Committee following the end of the Performance Period, which will be payable as provided in Section&nbsp;7. Nothing contained herein shall restrict the right of the
Company or any of its Subsidiaries or affiliates to terminate your employment at any time, with or without cause. Further, notwithstanding Section&nbsp;14(a)(2) of the Plan, in the event that you incur a Severance before or during a Performance
Period, the Units with respect to any such Performance Period shall be deemed to have been fully earned at the target amount of the award opportunity, and in the event that you incur a Severance on or prior to the Vesting Date but after completion
of a Performance Period, the Units with respect to any such completed Performance Period shall be deemed to have been fully earned in the amount determined by the Committee following the end of the Performance Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. In the event your employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether voluntarily or involuntarily) and
within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if not received) to forfeit, to the
Company the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of termination of your employment with the Company. Additionally, all Units granted
to you hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Performance Unit Grant Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. You will be required to satisfy all Federal, state and local tax and payroll withholding obligations, and any other withholding obligations, arising in
respect of any distribution of, or right to receive any distribution of, cash to you. Such withholding obligations will be deducted from your Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.
Except as otherwise provided in accordance with an election permitted under a deferred compensation plan approved by the Committee, any payment of a Performance Award shall be made (i)&nbsp;after the Vesting Date but in no event later than
<B>March</B><B></B><B>&nbsp;15, 20__</B> or (ii)&nbsp;in the event of your earlier Severance, within 30 days after your Severance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Any notice to you
under this Grant Agreement shall be sufficient if in writing and if delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in
writing and if delivered to the Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio
44316-0001. Either you or the Company may, by written notice, change the address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. The obligations of the Company under this Grant Agreement will be merely that of an unfunded and unsecured promise of the Company to deliver cash in the
future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the requirements of Section&nbsp;409A of the
Code. This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Units shall
not be deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from the requirements of Section&nbsp;409A of
the Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this
Grant Agreement to the contrary, if you are a &#147;specified employee,&#148; within the meaning of Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the
specified employee effective date, on the date you incur a separation from service, then to the extent required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of
compensation&#148; within the meaning of Section&nbsp;409A of the Code, that are provided as a result of a separation from service and that would otherwise be paid during the first six months following such separation from service shall be
accumulated through and paid (together with interest on any cash amounts at the applicable federal rate under Section&nbsp;7872(f)(2)(A) of the Code in effect on the date of termination), on the first business day that is more than six months
following your separation from service (or, if you die during such <FONT STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. In order to administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to the information provided in
this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to
facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the
country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Performance Unit Grant Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. By accepting this Grant Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy
Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation
Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms
and subject to the conditions set forth herein and in the Plan. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>d373071dex106.htm
<DESCRIPTION>EX-10.6
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.6</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.6 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Performance Unit Continuous Vesting Grant Agreement </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. This Executive Performance Unit Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear
Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time, the &#147;Plan&#148;), and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to
and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree that you have read and understand the provisions of the Plan, this Grant Agreement and Annex A: <FONT STYLE="white-space:nowrap">20__-20__</FONT> LTI
Targets and Ranges, referred to as &#147;Annex A&#148;. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other successor in interest
shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. Except as otherwise provided in Section&nbsp;4 or as may be provided pursuant to Section&nbsp;14 of the Plan in the event of a Change in Control, the
number of Units earned (the &#147;Performance Award&#148;) will be determined and contingent upon the extent to which Performance Goals are achieved during a Performance Period, as described in Annex A and as determined by the Committee, and will be
paid as provided in Section&nbsp;7 of this Grant Agreement. All Performance Awards will be paid in cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. As further consideration for the Units
granted to you hereunder, except as otherwise provided in this Section&nbsp;4, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until <B>December</B><B></B><B>&nbsp;31, 20__</B> (the &#147;Vesting
Date&#148;). In the event of your death, &#147;Retirement&#148; (defined as termination of employment at any age after 30 or more years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries) or
&#147;Disability&#148; (defined as termination of employment while receiving benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries) on
any date which is more than six (6)&nbsp;months after the Date of Grant and prior to completion of a Performance Period, you will receive a prorated number of Units; provided, however, that if you remain in the continuous employ of the Company or
one or more of its Subsidiaries until at least <B>December</B><B></B><B>&nbsp;31, 20__</B>, the Units granted to you hereunder will be deemed to be fully vested and you will receive the number of Units actually earned as determined by the Committee
following the end of the Performance Period, which will be payable as provided in Section&nbsp;7. Any such proration will be based on the date of your termination of employment with the Company and actual achievement of the Performance Goals as
determined by the Committee following the end of the Performance Period. In the event of your death, Retirement or Disability on or prior to the Vesting Date but after completion of a Performance Period, you will receive the number of Units earned
as determined by the Committee following the end of the Performance Period, which will be payable as provided in Section&nbsp;7. Nothing contained herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to terminate
your employment at any time, with or without cause. Further, notwithstanding Section&nbsp;14(a)(2) of the Plan, in the event that you incur a Severance before or during a Performance Period, the Units with respect to any such Performance Period
shall be deemed to have been fully earned at the target amount of the award opportunity, and in the event that you incur a Severance on or prior to the Vesting Date but after completion of a Performance Period, the Units with respect to any such
completed Performance Period shall be deemed to have been fully earned in the amount determined by the Committee following the end of the Performance Period. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Performance Unit Continuous Vesting Grant Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. In the event your employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether voluntarily or involuntarily) and
within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if not received) to forfeit, to the
Company the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of termination of your employment with the Company. Additionally, all Units granted
to you hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. You will be required to
satisfy all Federal, state and local tax and payroll withholding obligations, and any other withholding obligations, arising in respect of any distribution of, or right to receive any distribution of, cash to you. Such withholding obligations will
be deducted from your Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. Except as otherwise provided in accordance with an election permitted under a deferred compensation plan approved by the
Committee, any payment of a Performance Award shall be made (i)&nbsp;after the Vesting Date but in no event later than <B>March</B><B></B><B>&nbsp;15, 20__</B>; or (ii)&nbsp;in the event of your earlier Severance, within 30 days after your
Severance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Any notice to you under this Grant Agreement shall be sufficient if in writing and if delivered to you or mailed to you at the address on
record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered
mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company may, by written notice, change the address. This Grant Agreement shall be construed and
shall take effect in accordance with the laws of the State of Ohio. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. The obligations of the Company under this Grant Agreement will be merely that of
an unfunded and unsecured promise of the Company to deliver cash in the future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the
Company under this Grant Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the
requirements of Section&nbsp;409A of the Code. This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without
limiting the foregoing, the Units shall not be deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from
the requirements of Section&nbsp;409A of the Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this Grant Agreement to the contrary, if you are a &#147;specified employee,&#148; within the meaning of
Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the specified employee effective date, on the date you incur a separation from service, then to the extent
required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of compensation&#148; within the meaning of Section&nbsp;409A of the Code, that are provided as a result of a
separation from service and that would otherwise be paid during the first six months following such separation from service shall be accumulated through and paid (together with interest on any cash amounts at the applicable federal rate under
Section&nbsp;7872(f)(2)(A) of the Code in effect on the date of termination), on the first business day that is more than six months following your separation from service (or, if you die during such <FONT STYLE="white-space:nowrap">six-month</FONT>
period, within 90 days after your death). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Performance Unit Continuous Vesting Grant Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. In order to administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to the information provided in
this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to
facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the
country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. By accepting this Grant Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy
Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation
Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms
and subject to the conditions set forth herein and in the Plan. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>8
<FILENAME>d373071dex107.htm
<DESCRIPTION>EX-10.7
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.7 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Annual Grant Agreement Cliff </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. This
Restricted Stock Unit Annual Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time,
the &#147;Plan&#148;), and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree that
you have read and understand the provisions of the Plan and this Grant Agreement. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other successor in interest
shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. As consideration for the Units granted to you hereunder, except as otherwise provided in this Section&nbsp;3 or as may be provided pursuant to
Section&nbsp;14 of the Plan in the event of a Change in Control, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until <B>________, 20__</B> (the &#147;Vesting Date&#148;). In the event of your death,
&#147;Retirement&#148; (defined as termination of employment at any age after 30 or more years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries) or &#147;Disability&#148; (defined as
termination of employment while receiving benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries) prior to the Vesting Date and on any
date which is more than six (6)&nbsp;months after the Date of Grant of the granted Units, you will receive a prorated number of Units. Any such proration will be based on the date of your termination of employment with the Company. Nothing contained
herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to terminate your employment at any time, with or without cause. In the event of a Change in Control while this grant is outstanding, the Units shall be subject
to the applicable provisions of Section&nbsp;14 of the Plan, and in the event that you incur a Severance prior to the Vesting Date, the Units shall be deemed to have been fully earned. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. In the event your employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether voluntarily or involuntarily) and within
18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if not received) to forfeit, to the Company
the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of termination of your employment with the Company. Additionally, all Units granted to you
hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The Company will pay to you 100% of
the total number of whole Units earned in shares of Common Stock (with each Unit being equivalent to one share of Common Stock), less such withholding and payroll taxes as the Company shall determine to be necessary or appropriate. Any payment
pursuant to Section&nbsp;5 of this Grant Agreement shall be made (i)&nbsp;after the Vesting Date but in no event later than the March&nbsp;15 of the year following such Vesting Date; or (ii)&nbsp;in the event of your earlier Severance, within 30
days after your Severance. The number of Units earned will always be rounded down to the nearest whole number, and the Company will not be obligated to issue any fractional shares of Common Stock (or pay any cash in lieu thereof) pursuant to this
Grant Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Annual Grant Agreement Cliff </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. Each Unit will be credited with one Dividend Equivalent on each date on which cash dividends are paid on shares of the Common Stock (and each fraction of a
Unit shall be credited with a like fraction of a Dividend Equivalent). Dividend Equivalents (and fractions thereof, if any) will be automatically translated into Units by dividing the dollar amount of such Dividend Equivalents by the Fair Market
Value of the Common Stock on the date the relevant Dividend Equivalents are accrued to your account. The number of Units (and any fractions thereof) resulting will be credited to your account (in lieu of the dollar amount of such Dividend
Equivalent) and shall continually be denominated in Units, and shall remain unvested, until vested and converted for payment as provided in this Grant Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. You will be required to satisfy all Federal, state and local tax and payroll withholding obligations, and any other withholding obligations, arising in
respect of any distribution of, or right to receive any distribution of, shares of Common Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Any notice to you under this Grant Agreement shall be
sufficient if in writing and if delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the
Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company
may, by written notice, change the address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. The obligations of the Company under this Grant Agreement will be merely that of an unfunded and unsecured promise of the Company to deliver shares of
Common Stock in the future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Grant Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the requirements of Section&nbsp;409A of the Code.
This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Units shall not be
deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from the requirements of Section&nbsp;409A of the
Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this Grant
Agreement to the contrary, if you are a &#147;specified employee,&#148; within the meaning of Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the specified
employee effective date, on the date you incur a separation from service, then to the extent required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of
compensation&#148; within the meaning of Section&nbsp;409A of the Code, that are provided as a result of a separation from service and that would otherwise be paid during the first six months following such separation from service shall be
accumulated through and paid on the first business day that is more than six months following your separation from service (or, if you die during such <FONT STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death). You
will be deemed to have a &#147;separation from service&#148; on the date of your termination, if after the date of your termination you are not reasonably anticipated to provide a level of bona fide services to the Company or any affiliate that
exceeds 25% of the average level of bona fide services provided by you in the immediately preceding 36 months (or, if less, the full period of services to the Company or any affiliate). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. In order to administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to the information provided in
this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to
facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the
country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Annual Grant Agreement Cliff </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. By accepting this Grant Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy
Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation
Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms
and subject to the conditions set forth herein and in the Plan. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>9
<FILENAME>d373071dex108.htm
<DESCRIPTION>EX-10.8
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.8 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Annual Grant Agreement Ratable </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. This
Restricted Stock Unit Annual Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to time,
the &#147;Plan&#148;), and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree that
you have read and understand the provisions of the Plan and this Grant Agreement. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other successor in interest
shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. As consideration for the Units granted to you hereunder, except as otherwise provided in this Section&nbsp;3 or as may be provided pursuant to
Section&nbsp;14 of the Plan in the event of a Change in Control, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until <B>_______, 20__ </B>with respect to <FONT STYLE="white-space:nowrap">one-third</FONT>
of the Units granted; <B>_______, 20__ </B>with respect to <FONT STYLE="white-space:nowrap">one-third</FONT> of the Units granted; and <B>_______, 20__ </B>with respect to <FONT STYLE="white-space:nowrap">one-third</FONT> of the Units granted (each
a &#147;Vesting Date&#148;). In the event of your death, &#147;Retirement&#148; (defined as termination of employment at any age after 30 or more years, or at age 55 or older with at least 10 years, of continuous service with the Company and its
Subsidiaries) or &#147;Disability&#148; (defined as termination of employment while receiving benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its
Subsidiaries) prior to a Vesting Date and on any date which is more than six (6)&nbsp;months after the Date of Grant of the granted Units, you will receive a prorated number of Units. Any such proration will be based on the date of your termination
of employment with the Company. Nothing contained herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to terminate your employment at any time, with or without cause. In the event of a Change in Control while this
grant is outstanding, the Units shall be subject to the applicable provisions of Section&nbsp;14 of the Plan, and in the event that you incur a Severance prior to a Vesting Date, the Units shall be deemed to have been fully earned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. In the event your employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether voluntarily or involuntarily) and
within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if not received) to forfeit, to the
Company the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of termination of your employment with the Company. Additionally, all Units granted
to you hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The Company will pay to you
100% of the total number of whole Units earned in shares of Common Stock (with each Unit being equivalent to one share of Common Stock), less such withholding and payroll taxes as the Company shall determine to be necessary or appropriate. Any
payment pursuant to Section&nbsp;5 of this Grant Agreement shall be made (i)&nbsp;after a Vesting Date but in no event later than the March&nbsp;15 of the year following such Vesting Date; or (ii)&nbsp;in the event of your earlier Severance, within
30 days after your Severance. The number of Units earned will always be rounded down to the nearest whole number, and the Company will not be obligated to issue any fractional shares of Common Stock (or pay any cash in lieu thereof) pursuant to this
Grant Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Annual Grant Agreement Ratable </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. Each Unit will be credited with one Dividend Equivalent on each date on which cash dividends are paid on shares of the Common Stock (and each fraction of a
Unit shall be credited with a like fraction of a Dividend Equivalent). Dividend Equivalents (and fractions thereof, if any) will be automatically translated into Units by dividing the dollar amount of such Dividend Equivalents by the Fair Market
Value of the Common Stock on the date the relevant Dividend Equivalents are accrued to your account. The number of Units (and any fractions thereof) resulting will be credited to your account (in lieu of the dollar amount of such Dividend
Equivalent) and shall continually be denominated in Units, and shall remain unvested, until vested and converted for payment as provided in this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. You will be required to satisfy all Federal, state and local tax and payroll withholding obligations, and any other withholding obligations, arising in
respect of any distribution of, or right to receive any distribution of, shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Any notice to you under this Grant Agreement shall be
sufficient if in writing and if delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the
Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company
may, by written notice, change the address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. The obligations of the Company under this Grant Agreement will be merely that of an unfunded and unsecured promise of the Company to deliver shares of
Common Stock in the future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the requirements of Section&nbsp;409A of the
Code. This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Units shall
not be deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from the requirements of Section&nbsp;409A of
the Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this
Grant Agreement to the contrary, if you are a &#147;specified employee,&#148; within the meaning of Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the
specified employee effective date, on the date you incur a separation from service, then to the extent required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of
compensation&#148; within the meaning of Section&nbsp;409A of the Code, that are provided as a result of a separation from service and that would otherwise be paid during the first six months following such separation from service shall be
accumulated through and paid on the first business day that is more than six months following your separation from service (or, if you die during such <FONT STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death). You
will be deemed to have a &#147;separation from service&#148; on the date of your termination, if after the date of your termination you are not reasonably anticipated to provide a level of bona fide services to the Company or any affiliate that
exceeds 25% of the average level of bona fide services provided by you in the immediately preceding 36 months (or, if less, the full period of services to the Company or any affiliate). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Annual Grant Agreement Ratable </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. In order to administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to the information provided in
this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to
facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the
country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. By accepting this Grant Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy
Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation
Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms
and subject to the conditions set forth herein and in the Plan. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>10
<FILENAME>d373071dex109.htm
<DESCRIPTION>EX-10.9
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.9</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.9 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Continuous Vesting Grant Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.
This Restricted Stock Unit Annual Grant is granted to you under, and governed by the terms and conditions of, the 2022 Performance Plan of The Goodyear Tire&nbsp;&amp; Rubber Company, adopted effective April&nbsp;11, 2022 (as amended from time to
time, the &#147;Plan&#148;), and this Grant Agreement. As your grant is conveyed and managed online, your online acceptance constitutes your agreement to and acceptance of all terms and conditions of the Plan and this Grant Agreement. You also agree
that you have read and understand the provisions of the Plan and this Grant Agreement. Capitalized terms used but not defined in this Grant Agreement have the meanings set forth in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. All rights conferred upon you under the provisions of this Grant Agreement are personal to you and no assignee, transferee or other successor in interest
shall acquire any rights or interests whatsoever under this Grant Agreement, which is made exclusively for the benefit of you and the Company, except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. As consideration for the Units granted to you hereunder, except as otherwise provided in this Section&nbsp;3 or as may be provided pursuant to
Section&nbsp;14 of the Plan in the event of a Change in Control, you must remain in the continuous employ of the Company or one or more of its Subsidiaries until _______<B>, 20__</B> (the &#147;Vesting Date&#148;). In the event of your death,
&#147;Retirement&#148; (defined as termination of employment at any age after 30 or more years, or at age 55 or older with at least 10 years, of continuous service with the Company and its Subsidiaries) or &#147;Disability&#148; (defined as
termination of employment while receiving benefits for a period of not less than one year under a long-term disability income plan provided by a government or sponsored by the Company or one of its Subsidiaries) prior to the Vesting Date and on any
date which is more than six (6)&nbsp;months after the Date of Grant of the granted Units, you will receive a prorated number of Units; provided, however, that if you remain in the continuous employ of the Company or one or more of its Subsidiaries
until at least <B>December</B><B></B><B>&nbsp;31, ____</B>, the Units granted to you hereunder will be deemed to be fully vested, which Units will be payable as provided in Section&nbsp;5. Any such proration will be based on the date of your
termination of employment with the Company. Nothing contained herein shall restrict the right of the Company or any of its Subsidiaries or affiliates to terminate your employment at any time, with or without cause. In the event of a Change in
Control while this grant is outstanding, the Units shall be subject to the applicable provisions of Section&nbsp;14 of the Plan, and in the event that you incur a Severance prior to the Vesting Date, the Units shall be deemed to have been fully
earned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. In the event your employment with the Company and its Subsidiaries is terminated for any reason whatsoever (whether voluntarily or
involuntarily) and within 18 months after such termination date you accept employment with a competitor of, or otherwise engage in competition with, the Company, the Committee, in its sole discretion, may require you to return, or (if not received)
to forfeit, to the Company the payments made (or to be made) hereunder which you have received (or will receive) at any time on or after the date which is six months prior to the date of termination of your employment with the Company. Additionally,
all Units granted to you hereunder which are outstanding shall be automatically cancelled upon commencement of your competitive engagement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. The
Company will pay to you 100% of the total number of whole Units earned in shares of Common Stock (with each Unit being equivalent to one share of Common Stock), less such withholding and payroll taxes as the Company shall determine to be necessary
or appropriate. Any payment pursuant to Section&nbsp;5 of this Grant Agreement shall be made (i)&nbsp;after the Vesting Date but in no event later than the March&nbsp;15 of the year following such Vesting Date; or (ii)&nbsp;in the event of your
earlier Severance, within 30 days after your Severance. The number of Units earned will always be rounded down to the nearest whole number, and the Company will not be obligated to issue any fractional shares of Common Stock (or pay any cash in lieu
thereof) pursuant to this Grant Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Continuous Vesting Grant Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. Each Unit will be credited with one Dividend Equivalent on each date on which cash dividends are paid on shares of the Common Stock (and each fraction of a
Unit shall be credited with a like fraction of a Dividend Equivalent). Dividend Equivalents (and fractions thereof, if any) will be automatically translated into Units by dividing the dollar amount of such Dividend Equivalents by the Fair Market
Value of the Common Stock on the date the relevant Dividend Equivalents are accrued to your account. The number of Units (and any fractions thereof) resulting will be credited to your account (in lieu of the dollar amount of such Dividend
Equivalent) and shall continually be denominated in Units, and shall remain unvested, until vested and converted for payment as provided in this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. You will be required to satisfy all Federal, state and local tax and payroll withholding obligations, and any other withholding obligations, arising in
respect of any distribution of, or right to receive any distribution of, shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Any notice to you under this Grant Agreement shall be
sufficient if in writing and if delivered to you or mailed to you at the address on record in the Executive Compensation Department. Any notice to the Company under this Grant Agreement shall be sufficient if in writing and if delivered to the
Executive Compensation Department of the Company in Akron, Ohio, or mailed by registered mail directed to the Company for the attention of the Executive Compensation Department at 200 Innovation Way, Akron, Ohio 44316-0001. Either you or the Company
may, by written notice, change the address. This Grant Agreement shall be construed and shall take effect in accordance with the laws of the State of Ohio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. The obligations of the Company under this Grant Agreement will be merely that of an unfunded and unsecured promise of the Company to deliver shares of
Common Stock in the future, and your rights will be no greater than that of an unsecured general creditor. No assets of the Company will be held or set aside as security for the obligations of the Company under this Grant Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. It is intended that this Grant Agreement shall either be exempt from the application of, or comply with, the requirements of Section&nbsp;409A of the
Code. This Grant Agreement shall be construed, administered and governed in a manner that effects such intent, and the Committee shall not take any action that would be inconsistent with such intent. Without limiting the foregoing, the Units shall
not be deferred, accelerated, extended, paid out, settled, adjusted, substituted, exchanged or modified in a manner that would cause the award to fail to satisfy the conditions of an applicable exception from the requirements of Section&nbsp;409A of
the Code or otherwise would subject you to the additional tax imposed under Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything contained in this
Grant Agreement to the contrary, if you are a &#147;specified employee,&#148; within the meaning of Section&nbsp;409A of the Code, with December&nbsp;31 being the specified employee identification date and the following January&nbsp;1 being the
specified employee effective date, on the date you incur a separation from service, then to the extent required in order to comply with Section&nbsp;409A of the Code, all payments under this Grant Agreement that constitute a &#147;deferral of
compensation&#148; within the meaning of Section&nbsp;409A of the Code, that are provided as a result of a separation from service and that would otherwise be paid during the first six months following such separation from service shall be
accumulated through and paid on the first business day that is more than six months following your separation from service (or, if you die during such <FONT STYLE="white-space:nowrap">six-month</FONT> period, within 90 days after your death). You
will be deemed to have a &#147;separation from service&#148; on the date of your termination, if after the date of your termination you are not reasonably anticipated to provide a level of bona fide services to the Company or any affiliate that
exceeds 25% of the average level of bona fide services provided by you in the immediately preceding 36 months (or, if less, the full period of services to the Company or any affiliate). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Stock Unit Continuous Vesting Grant Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. In order to administer the Plan, the Company may process personal data about you. Such data includes, but is not limited to the information provided in
this Grant Agreement and any changes thereto, other appropriate personal and financial data about you such as home and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to
facilitate the administration of the Plan. By accepting this Grant Agreement, you give explicit consent to the Company to process any such personal data. You also give explicit consent to the Company to transfer any such personal data outside the
country in which you work or are employed, including, if you are not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. By accepting this Grant Agreement, you acknowledge that a copy of the Plan, the Prospectus, and the Company&#146;s most recent Annual Report and Proxy
Statement (the &#147;Prospectus Information&#148;) either have been received by or provided to you, and you consent to receiving the Prospectus Information electronically, or, in the alternative, agree to contact the Executive Compensation
Department of the Company to request a paper copy of the Prospectus Information at no charge. You also represent that you are familiar with the terms and provisions of the Prospectus Information and hereby accept this Grant Agreement on the terms
and subject to the conditions set forth herein and in the Plan. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>gt-20220606.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 6/10/2022 5:57:28 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  xmlns:gt="http://corporate.goodyear.com/20220606"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://corporate.goodyear.com/20220606"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gt-20220606_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gt-20220606_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>gt-20220606_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 6/10/2022 5:57:28 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>gt-20220606_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 6/10/2022 5:57:28 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="gt-20220606.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140612490018504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GOODYEAR TIRE & RUBBER CO /OH/<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000042582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  06,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-1927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">34-0253240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 Innovation Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Akron<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">44316-0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(330)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">796-2121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, Without Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>d373071d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gt-20220606.xsd" xlink:type="simple"/>
    <context id="duration_2022-06-06_to_2022-06-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000042582</identifier>
        </entity>
        <period>
            <startDate>2022-06-06</startDate>
            <endDate>2022-06-06</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2022-06-06_to_2022-06-06"
      id="Hidden_dei_EntityRegistrantName">GOODYEAR TIRE &amp; RUBBER CO /OH/</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2022-06-06_to_2022-06-06">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-06-06_to_2022-06-06"
      id="Hidden_dei_EntityCentralIndexKey">0000042582</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-06-06_to_2022-06-06">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-06-06_to_2022-06-06">2022-06-06</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-06-06_to_2022-06-06">OH</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-06-06_to_2022-06-06">1-1927</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-06-06_to_2022-06-06">34-0253240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-06-06_to_2022-06-06">200 Innovation Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-06-06_to_2022-06-06">Akron</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-06-06_to_2022-06-06">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-06-06_to_2022-06-06">44316-0001</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-06-06_to_2022-06-06">(330)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-06-06_to_2022-06-06">796-2121</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-06-06_to_2022-06-06">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-06-06_to_2022-06-06">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-06-06_to_2022-06-06">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-06-06_to_2022-06-06">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-06-06_to_2022-06-06">Common Stock, Without Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-06-06_to_2022-06-06">GT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-06-06_to_2022-06-06">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-06-06_to_2022-06-06">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;
M 4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " #/4,I4EXJ[',     3 @
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MBBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @
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MX3]>?P%02P$"% ,4    " #/4,I4!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,]0RE1G[P>;[@
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( ,]0RE297)PC$ 8  )PG   3              "  <P!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ SU#*5/.O"BP_!   0Q   !@
M             ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( ,]0RE2?H!OPL0(  .(,   -              "  8(,  !X;"]S
M='EL97,N>&UL4$L! A0#%     @ SU#*5)>*NQS     $P(   L
M     ( !7@\  %]R96QS+RYR96QS4$L! A0#%     @ SU#*5!PX9>H_ 0
M/ (   \              ( !1Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( ,]0RE0D'INBK0   /@!   :              "  ;,1  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,]0RE1ED'F2&0$  ,\#
M   3              "  9@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   )  D /@(  .(3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d373071d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d373071d8k.htm">d373071d8k.htm</File>
    <File>d373071dex101.htm</File>
    <File>d373071dex102.htm</File>
    <File>d373071dex103.htm</File>
    <File>d373071dex104.htm</File>
    <File>d373071dex105.htm</File>
    <File>d373071dex106.htm</File>
    <File>d373071dex107.htm</File>
    <File>d373071dex108.htm</File>
    <File>d373071dex109.htm</File>
    <File>gt-20220606.xsd</File>
    <File>gt-20220606_lab.xml</File>
    <File>gt-20220606_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d373071d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d373071d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "gt-20220606_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gt-20220606_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "gt-20220606.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "gt",
   "nsuri": "http://corporate.goodyear.com/20220606",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d373071d8k.htm",
      "contextRef": "duration_2022-06-06_to_2022-06-06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d373071d8k.htm",
      "contextRef": "duration_2022-06-06_to_2022-06-06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://corporate.goodyear.com//20220606/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001193125-22-171605-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-171605-xbrl.zip
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M407J/0K8!X6"=KC^P9\;#@*Y16(?N4\Z/3_)&KJ1LHR>DNO8BF@:7)**YSF
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M^-8TJW!:T$YUBXUT3<\-Y# \)8FJ?J7";8#"_?>\P@VW_DVE<,D'92TJL;4
M,-.E\;@$XQ;Y%A^"Q)*4*2:*8:>"2(:U;^SX L?ZLC5V+UMCZ[)-VM*PH)*T
MI2V4R!X Z0 H[!X A5D )/VT-KHX>U&EBZJX>U$55XD*W[)JNP$/?/(G>)T8
M:-E++U5ZQ[N7WO&L]&J3^SY).7Z&O<%>9NDR.]F]S$[6EME^Z:TKQM/=B_%T
M5HRMZ8X\=%"4!"NN"WX-J8)KT]O++EUV9[N7W=D&LFO1<->ZEUZJ],YW+[WS
M=:2WUYUK2O!Y?<XJAV_)+<R0U#$-0TUEZJYA41'U!I #-NPR"W-UN,>S717=
MK:N_5T#P#Q80*WH[Y&$R?C()3>'':2Y*A55^WH34B[ZBKUW_T*AT/K=J[0?>
M%[B=#'7R_;!ATOE;8(MI&F6-(PI':=EJ*W#&Q*0!QMW5,83P.BX.TV7$A]E"
M 0_?,=AE ^KT, F.':G$1%1AP 0+7&BCN@/A#+B B5D/1>>_WV!J:OAT%M7%
MXSCZN4E ]>$WIFS4XT-GD[=/VO'KB/6&+_\MJ6P>T;7XQ;=//D>V/H>WT_/4
MA!969FH67FLZDVY,>[?I4^P_KMJ'' !5ON@!/%?=E_,LGE'ZS]#S,E?HW;CT
M7-/8PKV!%:=S-K2@>3\//IAK,X=T<N1O'H0'XO<X>D4]IX)F06A[@;V:GE,%
M!GZH8)**\;K;E\M\^$?*U)\P*_\?4$L#!!0    ( ,]0RE3XRV]?K@\  &@X
M   1    9#,W,S W,61E>#$P,2YH=&WM6VUOVT82_BY _V'AX@H'D!T[2=,T
M<0RDMIL$2)-<XK;7^[8B5](V))?EDI+57W_/S.R2U(M?BLJ'N\,% 6Q3)'=>
MGWEF=G7RYO+'=Z<G;RY>G9\.!R>7;R_?79Q>_./@^.CP^.2A_(GK#\,-ZN3[
M#^>_JN]?GWUX]^'3R[U?WKR]O-@[5<,!;CHS16VJTY/SMS^KSY>_OKMXN;>P
M:3U[_NSP&UOL*9W9:?%R+S.3>H_?]3'>ENMJ:HN#VI7/C\KZA0I_CUU=NUPN
M35Q1'WC[AWE^W/T]T;G-EL\O;6Z\>F\6ZI/+-59Z]>[MZ_<O]RH[G6&IBZN9
M'=M:D4[JY.%'4FC;TL?/=K#VZ<D/']Y?MOK/;&T.?*D3\[QPBTJ7>Z?O77'P
M]P;&F%B3GCRDVT_5Y]HE7]2'LK:N4*\K7=3JU;0R)H=-;Y+YZ2Y$/CY4ES/C
MC?KKLGNL5*EZ9E31Y&-3*3=1?J8K+(C?SER>0S]YP!:I371M4H5+],24U?9-
M#GV6JM13H_;IND@U'-P@U]=?'3_Y]L7MTM%]SUX\4!!(EL/JM5-+UZBF2"&N
M+E+YT,U-5>#3\9)E0V#GGC]-'.065:$1??;HZ-$C]=%4T!SF3(SZF.F"/H11
MU6OGTJ71E;JTE?FZ&/ORQ=<Z+U^H3\V8[ .3E+I8CI1.74GBF,G$)+6=F^'@
M55G93)XY/A[).OL:8B J4MPZJ5RN:GB3=*"?(Y9'C$%"!'5'+'@]LWX]M [5
M*T_:5\JSF5QP(ID BL[-$LO0PU ,_B!79;; .OR,_*%TDIBR9LWQC*]MW=0F
MO%:W00P1V;C=S;"0SK+.M,/!IFW9E-=+_RL<IS/O9!W<I&MVYDS/C:J,%N'9
MM;Z6U]SZSC-=VAI!] ?%!LO6> J$IE:%JU5J)I8"PQ9;GY>E:9G<Z,(64Z^\
MJ2DKZID\(P(<WGM6/Q+SY'JIS)6I$NM%KETD><R=LJE\H\6[6ZU1SRK73&=J
M__B!!+)6B?:SX:#42[XAF$3GKL%?P>N3!G$AL=C)CF20H*$[ J:,#2Q,4B0S
M34[:MT62-2E=U,K;O,G@=>,:W[V&'.]UMOZF=73"1Y5!\NOD]P:9&P+)MX^5
ME4N,2;TDH6^2F;P5AH!J?,NJY".Q$=+:7-6D>8G8LG4M&)/IQ0/D=LA=,E'[
M>)O$^X\ 7*IG.#;3-?(C#,4*/VA;J1]U]051^+/.&A/A-@7VTF.MF.9W.#U(
M>7<7K"^\X1(]'(A6_(#R"UUNZH:BL?^X"Q&7CVVA>?&PVHI)Q(F;KT/.U3.7
M>L!:T8MZ><6.ZAN6A67&AKRVJ,B!!>$"&0804Y/R7?D;#JZO?S TWM(9*L+3
MFC(C@DPN$A!)+2Q@A.-/PD"@'<&(:*(?6(3^+PH WLR6RO9\M=56R@J^"5BT
MRE4FA#VDS(VII0CJ*Q9@YC).,3<&H].Q8EA/US@=4- HS#OS[\#P IC;2>-.
M\/(Q%\-)4U'J<R6S*!L2A('4 *YW")Z!>!#0<(7BJJKRQM<P?ZZ1X $<(0OB
MJF$8R\O,+6-2!/) V>-0B/$C=Q4;W-9>?6[&4,'",R; %#US'M)>D#IDNV!!
MQ3]]KTK<2+KNH.K8('3;D-9C *3N%\3KF1]KN*6@C,V$5"1++:S$*B[;.A.#
M[JK2#0=KWF**O!, :?G)V  Z8C!(YA'!L$1.@%YS47?5>!,P$F%61$UZ&"F!
MP28R5T2QR-  A+E-A:R4N@))TN5,/<%;,[<@%T1H_F1J9#L]+8BL]B/-P5NN
M7PELBT0E?XEDCX_:("32ZQG8Z2[<\<TW'*<9T6R&,5S/C/;4F+5W3_K![DTU
M)UQM02_&.V'>>H2CB*1&U[-1J*'G9#*;V7JYJ=)P<+U.\&I&^)<8RQ5T; H\
M5TMCHZEJ6Z FGB%?9<93NA#=+T3EV$>HS!73 UI&I:TD\ /G0TD,M'4.L8S0
M<+ $6,>7B!17=?W'>J9O9K@4T36].%)ZRHV!R[<94CD&0-:*=#[31'NH[X@&
MY/!Y<*C>NYI<P\PZUCW*SJG#7Z.(7A+(1/;5&=Z)2, '9_!RY;)@;<YT 0'\
MXIHZOG*T*\8Z'+2ES3?CW]!A1>C399FA#Z7L8H_XV'Y\IC;,%:'_>M+O2 [5
M#Z'+U7-GT]C-I*X9USL3^5:@V(H-JP& *MS+5E1I!+8'*6YC8^XR\&Y"77Q@
MI^'!_5X(\&T=/B#,.GSAVQ9,)L!YQZ:+Z7YC<(,A[Q(C]]\I/3E4%_]>G4:[
M8Q/1X0B !NK#@0D"9!DI\O98 :I0= 6REL;8:9E 08F)EH9N2H#1)K!5:"<!
M9<QU'&0;]R#D+"C$M'<%./%:= 7<[H)LI#KTOANLW5H>MJ+:H7J[YJOM\I (
MG40!M.YJ"W"HOAS[)%WHSCBQ^^_IBA\\"#Z=F$W.]H#<0ZNPJ\1/0$TNNJR>
MMU=J_VEHIM!O *%[#E[E?T'PG31&I4GXX\#JAH.[T[K=@6:$>:ZS-L\-[%Z;
M;+D*E44ZVD:3A!>MYV\7$YN>'W4M4V^!X2 F6"@3Q!-D&+JO@V/HLM#\5#Z)
M8\;=^2245.JMQV'5B9T':G93[&_34P!+D/CA^=N?3T\>AH'_<*#X_TF)#GB9
MF=6ANLDW )HN430<C($(7PZ$TC_7V4(O/>T,G+SYI#Z__2?4?KP77\D;#L^_
M^H[_[:E?WIY?OGFY=WQT]+=VW']V\?[RXM-_W&[$?^..P"XR,93/V)&EVY+A
MZL\EPU]K1WOIL&S7I;$QYT._MXJC,4F&4%W _#V5GRK\YJDF+F:HH/P,;S;Y
M"!YQD%YJ[X7%\TW<LE(U3!)7"6<6%IKIA9<5?<)<#44"?4-=V7%#;SH<#M;3
M=?<U,=2]7J6+A7+$!6=N/#'0W<%T&'-L8R98^;LC.&*)^CEQ&7 Y=AC1.3?K
M+Q0=E*UTWOCKZXXTBZQDZ!-I;H\R;7NA&<HRQ;"V65.U8L)[:">H6ZDMLZY2
MMH%"&,%U6'NC?85@Y H]F<#*/''I$VZZ@^;)T#LL)IR]G:[QN\$--(Q.3DH;
M&3O/EIZX'W?@T V_(=H*)!O-CJU]$$Q43/64W@7#TWY+D]0=B4A-3CLX%5Q!
MS>IO#9K=QL<@O5;^$=A'8=!& $R8_$0.S0M'2_+RJ,LT]>;9-%XU0<65-])?
M204@&@YL@;9D+OKJ!J6:Z@0$)"=6-!XC#1$O)<T]*\LA("-D.X\S9+PM/H4N
MQ[JL#1296$0DK4P6AK9N(X7NX+@%3>_B/3S.-]SXTFW>43PW=>"]'-[(Z:0R
M(G!J)(1YXJ9KM*BTB[!-:K!Z4]F6UNMT#@0B4J-YL]"O"\DJ1B&Y3Y^1BA3&
MFCMXDAI2QBPDG$EDQLLPMH7/\H\MW)X^ZLQ!@=+V(^OF#-,BV:ADV]( BGY!
MQQ\)^3T/>;_9W1SOSTSL9*Y?VJIKS&G?0 K/-:/9=3[]9Z:D3'!#UH;M)A*T
MK<61MJZVC+U64H+!%#SIXKB\U618Y8 4BM:22=G]=^]/#]69J6J8*A$LB@ $
MAX#5A]F,C/$22_@8=T=&+26Y9HNFVYR)L^;49&#0%;LVS.]=%;>ZN:"D#>5E
M@BQ/8:,4CA8W>)C93W32W]3J-O_KL*D(6+<ER8B<2C;Z2@3:JR\58<>'F75Q
MN,KN$8W+#!Z)>^Q!QA46T-*R-(Q[6G)R_X[Z=JWEN!5NMW(6VQMYI&NC!<"Q
MKKW#ZU$+ ,ULDSCB"K6)BTN\\(#7H(5M,1P</U,K[3(;MD\ST@!KP<(;PO/.
M90EXKRD&)Z.56BB5UTC=E;OHG?3@:#4:;B@G_?I!G@S[=)&,X*.FBK501M0R
MR3;I _H<YIH86X_6XD*&PNB9"Y?;1,UEFWAWHX$XNVRWNGKCI7A40PY<D,'&
MH4A%TMSM^G8%1 D37YM;M3R&1B#!E<@I2O+^/M=D8_Y_6R@>JE>IG$PAH!SQ
MN97[W I<M\\*>'<CAU7X3F@.G=%&6%,Z#K*<T"_OM?=TQ":$WCP&I+#E>ZZ[
MSP[5A;Y+%;EC%V=XXYK, K):^$F Y$#+NYQC1DV['K'SNDNS)9OJUJ\4\A1<
M&!R*(P72F1"%L'L?/^_1A-\A"(FM29^)7(72571V=X(M'$X)&QE\ &$[1:AB
M2XMRTQ^(;7L-6:O;0'QV?3M5.-08JBP\,@JN,::KR<#4!"T) S'^(P_!/B,;
MD;,V NBB)M\G-_D^ND<AM\G N8,N@FI=2OPGR1J/>(>K8KT/FWHA+=JC%VVV
MW[,KCX_DA$HX-[)R G&KLWJ;5T0,+!\ FI )Z0B*-%.(6 !;("@=IE"OA#ZR
MNQ"XAD[3BG8O$3PH$:Y*X^CBXLHD#>,#F<,47E#RW"  ZG!H<$7V?LG>@0YJ
M184[2220?C-1"D884\V<(MEY ;J(U(<!ZFZY^)(8+)K.^/1IV^WRP,:/CHY
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ME+2]1.[:LV8Z@PNIK9_3EI5\)\2U2'!7+KD>'31DH2Z%#M^7C"P]TV^74=/
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M#'T5,)&X>7??4]I-Y^'@N_M+^=R!?Q#KX-Z6#R5C.@*(A$OS.YRD>>"9BI[
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M2'\(YX$=&678;>+=RZG+FWA:J_IU"D=@3F$NEP,K8D"2:G/29 'D-.3>>*C
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M[C1,-0)LJR*7 _B)-N#OM-$LAEN3ZQ<9 O&"J/N%B*RR[U+B_9SK(+VGTG1
M4!$N0*K/$/ H"U4+P-H:4^NPU"6\'@(DM".@&*&3954]#(-"CJ3.\"Q?;>6;
MRO;2WXB!]N#LXA>0Z=A7['84__]XJHHPS\QB_)G)2OC15U/LN3N [W_:%< ^
MU-E,SPMJ0!Z_OE17%_]&(#_:JK;DON;A=\_X?UOJP\79]>OG6_M[>_^HNXHO
MS]]>GU_^US4]OZSQN '&ODKG\:#/C;\J<-CA$3E54X.46:%L< $"-I1G-J80
M7B ^PC"\X3X!Q3R<Z2JXY!/PBWS:@#KR$W!!<D<*]QN=Q9*7:#@_WCS=[?#C
M.SVI"QC":"<<S?[,I%K/48)GR*JWAGEG&W3%X>NL$C$@-]2%T5YXSA14"F&*
MV!0>'9%C<X/@8&-CJ(XO 1T;2X,&)U9R,E26NYA",BW+-.Z-FO0G[9/QNC)U
M_T#*U".N4QD=JY.6FQ4"+=IG%CO7;$'(&-:BL$P181'(>'&]2#SCKIZ&A"==
MU[N2N[RIF^45V.5&<W-+_$3VZ2TWFV0C0O8!\-L-$($Z=KEM4932#!MZG0CZ
M;70OXCYZSJL377!W$5<NZ2AOW'!GP9CK&[4M(HHZ@K@U1#VO/;1HD7";"ME:
MTTE:O_<W9R-/I-%<B1@3*>NQ ,P7PSEGC1\-=7*R'B"4')",D;E$<_ L!%,[
MR*)5J",J]N/*@-G(YF7>%O0EM3DK\DADDXKI5L^PHA52A'#*C[7NNH7KC?_M
MF\<_""[ 2ZEMTA[ W(T"W4Y1HE)*+'T) @.GG'D;*N"RU$O-<%O?C'6HS:-M
MUGP12P:=IIX0$)>&BIRO>?/YK4E*3LH4428OA%6<F:GV(4Y-%F1O!]\][J"^
MZ K,PCXKTG+[CIJ3GSR1P'=CZWHM)0R($X[@!WP ?0FO@ )"?5R]2=69U(%:
MJ)%9W4M#I..'>WN@\[F[D1\_:-"LEDSJ\>-'^T]V]_;V]OOJW++O1W.U9.AV
M)O0<]<T]L=T\JKVG$ND8MRP9)WX;U<Y3*E_&7K%\'?0G$T=NI#/0=C@"<XB:
M,59->OK[*D2Z23?X&S#HJ62,%@XL&_H.?ZN0:P)+9W.I=!DP\-!0D@LIHLP+
M6).< >@[H3IDZ0AX1?3(!BZX,&B218R<88GJP@BB<>:+,Y=*$J0!2%>GY$61
M*BE&)B= 52AC4JJ3J/=",R :MBU)5NT[-AFG#QJ%:6JM$V?A_:AM5;GQG]+B
MWV#D9RA[>?1*<RDV"^OE#@PQ$BX#FFZ@R EQ%$RA,)UFJ$#:B8";"O-6&1DS
MF91R4,0"$7N\]^RTT4YJ^MW./:.*1M@@A!6R+(S1*;1HF)R+Y4,,N4@_^=YA
M@<C$_H2<0ER& Y5K?A96=IFY$H8?&&Y9YP4=7=5ZK8W[ZD/LCV5V(D#+SHIR
M:.3PJ=V::0ZD7)/&>6Z/Z_G,<*>X)R.EE/X2WE)"=KA>R$0)OY4%+RO*09R*
M\S,"6*F,'5([M.OT(C?B/EZKA46%.0%UBWK$(4YK<$XC<[$^M3-E6,3SI<HW
M[FMWBNW4++8F1"[<Z#="RMA,B-@;RV@F/'8R==0;EX"ZV[.^.<EXN]3^A/LL
M-W$7QNS=SFG[O85J3N91U?0H+S-YH&%AG$41!Q,[2J?!F%Z<XL1:H#6G_VR@
MQ6YN-4NKIF>QK*-5J\<I8M0!WR6M]E,514UO[Y\:A;"?QTIGW8[=3KUE\_X)
M[=9;F'*T^Z0%)7O=>%@<@7$PU05+'+[6W-E2CX>AUK5QZ7.:T5)"B^?>D?$X
MA)J746I#21S#12EQ)2W*\E?,Q8?Q:PM5T4+OYE!?M\SB5'N#CJ*)ZG!OPJPJ
MA6)/G<UH/;W.T+2_&KLRQFTZHV',P*YR4F92!(Y15X[&L3"Q]1!+3AF4J#"(
M$Z<Z\H65V=R*$)SG-PF!(K*.G-2:ZEXL^/&/[]Y>UTVCL0UFMYCJQ!SF;N;U
M=.L$Q^WR<<</:.E)'&O6E?:SU4J;)U@[_^^@_6]WT/;W>!!0(T7#*UJ#JC9]
MHT8WHI Z4,U+1$ LK?2 \CY\HZ^NR.GX2T!85J;TPA:WBPJ9DA,W:&H@F[,N
MV*5;<T&:X&YX78P;)9SC"^F1!*J[F*BU^F&-?/3,T.90MUV15B($>#*F23RM
MK$,S%CM&WCQSU0LE07,%4PN]W%9HWX<C>\+]@6:<U)9Q:9X?7+<SU D-@>E7
M2?MB$J_;=:&\>/9B'L<? F'K7JBB*XZX[7U+C,4*:K?R;JOVJ Q;3\D6+-QZ
M&_"^&U9OD6W8D;O[5$,P%4IHAN:YH&[&&C/G/W&?$S$2$V?:BV[%A+)%%LBW
MM/JY?]6GU, )NYJN,.>$ZKFJ+'IMV0P[D:YX=O38E>&7V%;$I[?9'!\)UP9F
M,-ZO6')=,/T--<[^_KW]0B>?D ' I4?QU4X:FDWG;1^3Z'_O'7?!RF*E!TIY
M_<D1Y:Y"!EQTC(#9I:%Q,#^ #6[GU ^'JCB,6^\G-9L#BNK0B6\J5058,W^M
M9UR#^4(?4UI.=47<]LKF[9W%R[3/4R@ZDN!=+E,EJN?J$;W.8$.:>-T00Y(W
M85T-!9O;--W.YK81B_5[23UFC=0W96QIZ7Z]D)I>727L\R/3BD=OIO#XA2$[
M>2>[B-6^Z; TKP*O>4=WPY&YO( QJ'QJ/2&,[(8/D+>@JQ*FX?=5"=6\1QO?
M[&B]*[ 0)6M8Q?$#^@\#\"7_]P3_ 5!+ P04    " #/4,I4$8_=Q8</  "#
M,@  $0   &0S-S,P-S%D97@Q,#0N:'1M[5M;;QLW%GX7H/] N-C"!F3%2N(T
MB1T#3NPF7J1)$+O-=E\":H:2N!D-57+&LOKK]SOG<"ZZ.4XW7NS#%@4LC3CD
MN7[GQAR_N?KE[<GQF_/3LY-NY_CJXNKM^<GY/_8'!_W'QP_D*YX_B O4\<OW
M9[^KEZ]?O7_[_N.+G4]O+J[.=TY4MX-%KTQ>&']R?';QF[J\^OWM^8N=N4V+
MR?.G_4.;[RB=V7'^8B<SHV*']_I0+9MJ/[;Y?N%FSP]FQ9&*WX>N*-Q4'HU<
M7NP'^Z=Y/FB^C_349HOG5W9J@GIGYNJCFVJ<=/KVXO6[%SO>CB<XZOQF8H>V
M4,23.G[P@1C:=/3@Z7<X^^2#\2/G\3$QZG*BO5&OL-SFI2N#^LT$?!RKUU[G
MA3H=>V.FD!I3M5D>3[X'38.^NIK8T.VL$R>4V*#&],&DJG!JX4I5YJGQ/:7S
M5(W=M?$Y?AHN5#$Q"DJ>!OXE<7EJ"^ORH-RHQS\^/'CX4+6/^9#I'+^" !SF
M7+HPVJLKZ\V/^3#,CG[4T]F1^E@.A\9#4M.9SA<X-G4S(L:,1B8I[+51IS-O
M,WEE,.C),;L:9$!^*5:.O)NJ HP3 _27R>EV?OQA\/BG(R*"/CT]VA.>"HAC
M50M]=1J(=R^R(*& P6NSP/;T#OC18WQV>69S[,]+Y8O226)F!3.,=Z#DHBQ,
MW$W7:@9IM%%K,02CLVR;2%FB+,#M-/\.9>DL.#D&BW1!QW8[$PVQ>:.%>-9G
M*&0?HV;>7=NP>DQOXQG\_FF>FQMU^AR2__Q909:'!T?R^>W5A;J"@9I"./BH
M\[$)/1P],MZ+14%1HHBXC>BBKU[IF2V "W_2,I9!&<C0RD+EKE"I&5DR/)MO
M)HQ9).*G1N?PJZ""*;H=V%XQD9>$K_Y].]A#V [4R(##5A-9+V<N;]QIH^0W
MR1M^.8.V7*ZSRA])LCD),@!$#5DW7@HX!CIW,$-L[;N=4,*T0L #<&\)C@$X
M*DS(QG3R1PFWPTZ+BE!>)XN"FL-R@C/P]9K:==IZ6&:3"?G&5*=&F9LD*P,<
M-%M 0L+AT.306T'L5933X]JY\0[,G]!D;D%7?"O3<Y9(:D)2&5UJ0^$MK 'B
MZM\&W=]%B8_ZZEQ(@[FR0.<V1(6E+2N\)$ARN8#1(Z)?DS068+Q9/"M]*+7X
M_-(+@\=+CAVM%&+/66):O9J0 ]$/%#B\RR*2Y>64,!)K?LTM] 4<)=]@&>+D
MU) #L;M$'*%(0[NR$?(A-T5$(5%B&Z9?.X (6YY.)A;D0/JEIUBEE^'<>.O2
M'K%,FH)V1#+1L07?0IN:&#6@_JDM"F,89D>E)P$S6$)>7I. :@L2!F-$ZG:B
M"V"]B6')?+N>&*_5M(0_>#/5MA9]TH1G,YUE;E'I)QHLNU?.7C9UGB&;J+LL
MAZ#<:F]A126VR) <G9R9Q)":CA^\/,'7^">2P''K\V=ZJ';I!,'$*BDXTX6)
M0:JO+G+PW38,#B6IT<6D%]_[: KX,WFEO*5V*[R$7$3\(E:\+9P)NA0, 0AE
M2H^P3#TZJ'FCX SH)I,N>,7A(;.?$1[,+5 5SS.C V53]>I16X;!^&L+0^'5
M;3&29:P*;@^[5S'ZS 8]M)DM%M_$#DPYHSB7&'M-4HSH$]B8-.$H[)7>H8"2
M 1PI1.:L44Y%!.NTREP^WJ=C"'4B(3"1Q"&EF)&GUO8%@]8Q*6(*<$Z BP%U
MEZQ]R7;6;0:L0\6T)H7>6[!*>F 2@[U1NT_VQ'BFD/ D1(W1"60MM*\ - D7
M&1+YCX,V(!Y3R6JS_Y(S,'2(Y R)RCOX(7A809JCFO6>FK@Y18B>Y!E6$/Z;
M_:G;N9M#U<;V#9[56T<0M0H@+="$__#O^#(J,T2Q:WACQ- U&='.JS"LDZ+4
M]&+$X]O!CY*3+'-SLE1V[SRMP\$&+8E55-3.]$(/8>PXH@UV2SAW"'B%C)$(
M3*)"R0RJ'88Z< ++!Z;1@AA9;G&P38XL7%>Q8AHQ:I6-&%10>-PB$O4-$B%<
M5%MAL0%$LJT&3XAA/*C]@S9H@R[GF^)9?\EU-IF%6 ,<_%9S^!;>_Z(UO$.$
MI/W)+34306Z A9(54N[G;5+PH9P6;@A__&>#E])/HQ%DK*G8(<E&*X*=LV+6
MPXZ49FQ33D**@_ 3C;R_KWZ6K*!'6$T_<;U"Q*]D4+MZ;_?AWG+ELI1(5540
M 3A58-@ J,7"')H1@XZ_/;]I0(1IA9AF)HD57'2O]=>0@+-0EY"%BY2A,7D$
MF HG1.0%5TXH8UW9^)">:P]+F,U0R)0@8B%%ZUU9_+[F_G5)=#MQ'["UOH.Z
MNTPB@U$8WPTS[KMP>+P"2ZNF?Z=4B&)_[3ZI9"]4J2'^$8 WQ=GN?&(X=[YV
M&<2$E[.%5'*M!WM\!AULD64,GJJE_('-MXWX' JX6./6Q!KQFBT%AE)00C/J
MU24G9]XF'VNI6*I5$G,(DY<JOR4=LLN2%((#BB'I2CQ;8H]K*6^D6B6B8##X
MJ?0YG[MK)9>+Z)ONT>\0U\A8E*?1WN.1DD,#*8F56++NBE? 'NGK7CLK8'SE
M3$%Z)W( O]$&_+TVF$5O:Q*SY72.DK@H^R6'K(+O2MS]FNGTJ1G+UOS@[.(W
M9$&QZ=KM*/[_>*9"L<C,<F/33->,G![-H+7](2SLR[Z@XG.=S?4B4'?V^,U'
M=7GQ3WC+HYUJ2V[Z/O_A&?^WHSY=G%V]>;$S.#CX6]UR?77^[NK\X_]<1_AD
M4^OS/^K+#AY^#[).4VGV40+9XT[@IL2UVUFU42(?<;..CS7$ZA*$P)H23DD3
MXC;+JD84O!-<)76ZQL96N^QUY<C25[SGCMEAGSO"%2*R>\%/JU2=C HDBO\6
MKD"NV618\PDAQE(71/(9;[B%1! #=B\+EWP!7)(+&62J_ :$1 (C=+G666R'
M4#7"KZ^^O=>3DI$!DS;"R2QPKK?TPCMJWNH;$[A(;3$D&JE#6$2<W%![3GO)
MJF;(VP *0 ))VB-.=3M;FT>'6WN&M04(QME8-C:PM)8!0&2YBQ$KT[(,52>*
MJE^T3R:;ZJS!85-G'0D65P>M]K$$R+3/+#:N4Y->#$G4<TB!-!$V:7&W4Z\2
MT[BMWR4X1>QZ5W+_/W7SO,+6W&CN>XJ=R#Z]U3ZD;$2!!+NX(9!(1X^S(932
M)AUYG8A[;K4N2K3T@E<G.G#7&2R7=)(W;K2WU C<V,'O=EII+ZH6RN1!ZGEM
MH:&5\MM44KL-7<;-XX%[=N,G,H"H"(Q1F\48 $-AM&!4^]E0CR_K(9*0^4$5
MW4[F$LW.L^1,;2>+6J%>N:B/ZQ#.?;8O\S;00^BARE0ILZ4V2ZN97.4P4O!P
M?A&[()L6;M;]_>>5/PDLP$:IH=8>S'T% T*)JBRQ] S)$D0Q][:H8,M2CST#
ML[[IC% K1MNL>1"K$YVFGO#/D303YZL4O=LYOS%)R4&#_,GD05*8,S/3OHC3
MM"7:VZ[WW7F@S;]*T6IA2UWK+YX2SO<3ZWHM(0PI_QS##'A_>@BC@ "J;G1[
MEZIGK0MJKL<T[F[T0,@/#PY0.^3N6G[\I)$&M(A2CQ\_&CS9/S@X&/35N673
MC_IJTS"EUVB>XBFSSJ/4>RJ144)+DS((WBYU'E[Z,C; Y'&AOT#A,HHEH:%&
M@"5P(E6GI]7TACY?%C&W)0[N'8&>2K1H@<"JGF^QM@JWIE!TMI":FN$"+XTX
ML%"+EJ:G <HD8P#T3JGF63D#1A$-<ENDB %R5**0,;VJO^BK45Q%"4( J&O"
M\1))%1%CDQ.<*E1,*95DU.6AT2"-8%<(J_:=F(Q#1Z!F XU<*&'A_:A!5AEQ
M2XK=SIW%>.\Z?H8"F^?Q-*WD<,]BN05 C/C*D(9>**>*>#^ '&$VRY >MZ,
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M'R!]CZJ<:7+]JIRB/H+<LX[725H7%):<9$."<?R _A4)'O(_/ODW4$L#!!0
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MB-D24+Y!)>H+-+(9%EM )-]J\80VC =-?- $=;G*841,6R+K+X7..K<0;T"
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M<W]'\U9B?V1;D @80!]WNDR,<UJGER<+\!O=)+O332 1X5HRO$BAB3A'W2^
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M+HK,)GJ4K0;%6UA/\JPEZJ/<A*T-.%->A.D +^=!6S&X4;Z40AR3.^<5(V/
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M6(Y8W%')V/%L#@<13T?)PX<FJN%X"Q8"&>D9?)W)A<EHHQBQ6OI16T^T]MF
M7C_JK#(;-=4M,;@*,)FY(>1L7)O4CQS+5TVD]O29A-K,6*R3+H^$EA9@O"IC
M,ET#RLK:(-G(*?$(MZNCW^L8BTE/+!XK:E8[9]ZYJ_-5K!\KN'9X;%Y4^0W\
MS*2#V'N03W6#$WQ=Y[LQF%%<7&O";".\>W/$[Z6;6FLVYJ.LV0#LA?&"DZ\?
M#36=L@'8L"Z2,Y=H#O%+(;^;"L100=84?7&)R$G]]F$>E1:^I'P>AB\0X]G!
M\L52OZW.SJ48Y<PYUM&;!FZ.2/>>R3V5Y 6!DYHRW4N&VS.5?B]4J)@32U^"
M%0".N;=EG5U9:D-F.*QOFWW41-(V:[_04JSK-/64IN',T)#S375Z_L4D%:>V
M%.1-'B0W/S.%]F6\&5B2O9L/W.$,Z@\= 8O#&;\FTFK3 8N>?O942KV?6C?H
M*&%$E=4$,. -Z$N  @HHF^V:1>H>JD:QEM=\?B<-D8X?'!VA*,[=C?SX2:-8
MZ<BD'CUZ.'RR?W1T-$3 LPS]:*ZE\FU&\ZCE[*EFS*/:!RJ1UD;'DG+!M5WM
M?!/#O-L25*D1KN1:B71&9.E3;D$T=5?=WZ:_7Y6Q:*,3W#\#/9.(T&&!53O?
M K>:MV8P- 5)ZK8P76#26-)=N0D*,"9A 8P[HV)^90N (@*R)8M^;RD"1L<9
M5RC1C? 9QYYX6U%+@LH!TG6KAHY(M103DQ.=QD#F/+7@Z/;$E&N'K]>=FBSE
M=J>AR(&@0?&#UZ-F:8WB/Z7%^[?Q\.A 77 ;CFYTV"RLEULHQ(BWC.@6Q\R*
M,MYVMIVY;AB@4CU;='HQ,8Y)/V2U:??HZ-EIJYW4'/1[=W0JNJ5%*E 3R])-
M,7D6W9?F8ODR>EPLD?G<Y5)I)?VAN M55^RGW#B3Q))7F;L*AA\9[H?G@;:N
M&R:=A0_4I]@FS>Q,>);!BKIFXC:V/*6<0VEIY#9PP$VQS' /FJZ,Q$Z#F$97
MD!W0*S-1PC\K275"-8H7OSQ'^"J5.XW4CNTFO<B)N)TK]IQKS[0\)I[N)![Q
M+JAS-TS7M6U?5JZU^"*LQL9=[4Z^G9KE_I[(%?O =4<N4F_L17&Z8V>%HZZ[
M.-3MR+KO%..=*PD*3;L+Z%EIY2^GEOW>:?=FOKYM\]HON #AU(&2]W@S1 F8
MF%&Z=<8,XA51[$YT[K>_ZF>QIW^&5(VR_WC3.(R-)QJUOIVB3+W$=TFGA5L[
M4=MS^9M&ONX7L3.S:<5^KUFR?6&1<K>]6]MT6_6!0KUN 1:OU]B7F@X*.TK9
M)LZ6^J3,M*Y+2U_3C)8NGP#WEH#''M0^MV@,)6X,A%+<2CH)R[]C+MZ,2^FZ
M3J'7)[$@D[IWBXZBB1IO;[UL% OS%(&K9BGK0]EM(:_TTK;MT>;+H*YJ5DEU
M7$Z]JR;36)78YG9,=AE5*"\H(TYU3!?6;O;6A. POTV(7><;STFMJ<_%@A__
M^/[===/\F:)DW0^%3LSSW,V]+G9.L-T^;W=\2$-/XI5IT_M[=J166W]\#[W'
M55N_5R<'*Y=#C?=NECE"XBNWAM*06.[W;[I<K"E#+BOH&@?D3&T^I+"VJ#N%
M$4'4/#$WAF"J1A@)J^#+*%=8S<WCY5!S?:CDI0_QODF#>O#XVQJOFOJAR)1O
M6[Q[B2QNSE/M#*JCU2%T064D$^G#)S4.:@-3NWL04T!RUN9R^Z[2[_T'\JPA
MW]$U!-1F*YT[RJZ,= <%O5#OO7W4 U-KI4>434!/!^JJDG:;)F;,JM1 #]PG
M#W*Q3QE'6UC9G-_!,38Z_0VZL-CTFBBV!21SB%V?DHHY3O\Z-P&M?-P_ _SR
MQ*Y)*XX'FIK2XP$:V7A\K*",/#J3]3E,<EG4"+W:JNB>APECQCV'UNNZ,JX\
M0:!7,F.=T(.&NG%6F\3K;K$I#\%^6,2;26'&30^<Z(@3OI'Z0GF0E6#0">>=
MBJ8VK&[>#W0MW'E&=]<%ZU==6U;DBS=R.4ZPN"/GN4IO;QSGSG]FQP!AQ'B<
M#B*L.$WMY""$+:U^/K@ZH(C#>4!S\4F9++>SZ5'!H"N;81#I.GN/B%V[EQ;;
MBOCTNLSQEH"VG4BG;\V2FYSI_Q<2_RL7$L,'=W8_G7Q&_$8A-#$Q0X++%(NN
M*PO)?O".&YA56+M2HQ#\Y 5E'D&N^//F_)>F<%Z($0M\6?1[C'+61>?E6KLX
M&+]AJ/B&K:Z>VZ<BS2W_B -30\S2+FS:&5WG;]]U+1^FNY]"Q9B4WN5R2T'%
M^* .K#H#W"A)N*'\5E[JNH9QM[?8^KWM+3\6Z[>*KBPU/*9@"N_H?K.0FA[L
M4HCQ$].A/6\0[\/2*QTB 8:(U;[MCK5/E3>\(=ZR)093*!O5F-J<SL<<C#=
M&INW]6=;G=7U;_MZ.#[.ZCPV^AH9'1_2OV; E_R/(/X%4$L#!!0    ( ,]0
MRE06NV6^P@\  % R   1    9#,W,S W,61E>#$P."YH=&WM6VMO&SFR_2Y
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MK[/R76M[J::^=NW_Z(3K[=:T;!+8-I'AX>#L]/1_6M")#G5=EC"6,_(R494
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M[&@M2G90C/-[]$]"\"7_2Y)_ E!+ P04    " #/4,I4E2+E6=D/  !8,@
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M1;R1-)&$@FWQ4^-+WG?;2I@)A)KOP*4=Z6MD+!+#@)NH:LYU-1\EY(K; BY
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M;*JU:S8*Q8^.* .IY-Z_;-]X7YB9\^*Q6.#SHM]C];,;)\__NL5!1:WKA(>
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M4$L! A0#%     @ SU#*5/C+;U^N#P  :#@  !$              ( !8 \
M &0S-S,P-S%D97@Q,#$N:'1M4$L! A0#%     @ SU#*5"LC\:Y/$@  W$4
M !$              ( !/1\  &0S-S,P-S%D97@Q,#(N:'1M4$L! A0#%
M  @ SU#*5***R7DV#P  5C   !$              ( !NS$  &0S-S,P-S%D
M97@Q,#,N:'1M4$L! A0#%     @ SU#*5!&/W<6'#P  @S(  !$
M     ( !($$  &0S-S,P-S%D97@Q,#0N:'1M4$L! A0#%     @ SU#*5'T=
MU_OT#@  ,3   !$              ( !UE   &0S-S,P-S%D97@Q,#4N:'1M
M4$L! A0#%     @ SU#*5-2.=ZM/#P  /#(  !$              ( !^5\
M &0S-S,P-S%D97@Q,#8N:'1M4$L! A0#%     @ SU#*5/-L7/F2#P  "S$
M !$              ( !=V\  &0S-S,P-S%D97@Q,#<N:'1M4$L! A0#%
M  @ SU#*5!:[9;["#P  4#(  !$              ( !.'\  &0S-S,P-S%D
M97@Q,#@N:'1M4$L! A0#%     @ SU#*5)4BY5G9#P  6#(  !$
M     ( !*8\  &0S-S,P-S%D97@Q,#DN:'1M4$L! A0#%     @ SU#*5,K$
M'A)' P  7PL   \              ( !,9\  &=T+3(P,C(P-C V+GAS9%!+
M 0(4 Q0    ( ,]0RE33UT=F808  +]#   3              "  :6B  !G
M="TR,#(R,#8P-E]L86(N>&UL4$L! A0#%     @ SU#*5 <[AL>\!   ARH
M !,              ( !-ZD  &=T+3(P,C(P-C V7W!R92YX;6Q02P4&
/  T #0 R P  )*X

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
